Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Abbott has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday, ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...

As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...

This is the first time Retta has spoken at length publicly about her diagnosis and she says she hopes that others are ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

Stock analysis is all about predictions – but as wits from Mark Twain to Yogi Berra have reminded us, predictions are hard, ...

The blood glucose monitoring devices market has witnessed significant advancements and growth, driven by the increasing ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...